PL425238A1 - Application of 2'-hydroxy-4-ethylchalcone - Google Patents

Application of 2'-hydroxy-4-ethylchalcone

Info

Publication number
PL425238A1
PL425238A1 PL425238A PL42523818A PL425238A1 PL 425238 A1 PL425238 A1 PL 425238A1 PL 425238 A PL425238 A PL 425238A PL 42523818 A PL42523818 A PL 42523818A PL 425238 A1 PL425238 A1 PL 425238A1
Authority
PL
Poland
Prior art keywords
ethylchalcone
hydroxy
application
prevention
treatment
Prior art date
Application number
PL425238A
Other languages
Polish (pl)
Other versions
PL238124B1 (en
Inventor
Ewa Grela
Joanna Kozłowska
Mirosław Anioł
Agnieszka Grabowiecka
Bartłomiej Potaniec
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Politechnika Wrocławska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu, Politechnika Wrocławska filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL425238(22)20180416A priority Critical patent/PL238124B1/en
Publication of PL425238A1 publication Critical patent/PL425238A1/en
Publication of PL238124B1 publication Critical patent/PL238124B1/en

Links

Abstract

Przedmiotem zgłoszenia jest zastosowanie 2'-hydroksy-4-etylochalkonu do wytwarzania leku i/lub jako składnika produktów leczniczych do leczenia i zapobiegania kamicy nerkowej, kamicy moczowodu oraz kamienia w obrębie dolnych dróg moczowych, jak również zapalenia pęcherza moczowego oraz do wytwarzania suplementów diety, środków żywieniowych lub jako składnika żywności funkcjonalnej, stosowanych wspomagająco w leczeniu i w profilaktyce tych chorób.The subject of the application is the use of 2'-hydroxy-4-ethylchalcone in the manufacture of a drug and / or as a component of medicinal products for the treatment and prevention of nephrolithiasis, ureterolithiasis and calculus in the lower urinary tract, as well as cystitis and for the production of dietary supplements, nutritional agents or as an ingredient of functional foods, used to support the treatment and prevention of these diseases.

PL425238(22)20180416A 2018-04-16 2018-04-16 Application of 2'-hydroxy-4-ethylchalcone PL238124B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL425238(22)20180416A PL238124B1 (en) 2018-04-16 2018-04-16 Application of 2'-hydroxy-4-ethylchalcone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL425238(22)20180416A PL238124B1 (en) 2018-04-16 2018-04-16 Application of 2'-hydroxy-4-ethylchalcone

Publications (2)

Publication Number Publication Date
PL425238A1 true PL425238A1 (en) 2019-10-21
PL238124B1 PL238124B1 (en) 2021-07-05

Family

ID=68238665

Family Applications (1)

Application Number Title Priority Date Filing Date
PL425238(22)20180416A PL238124B1 (en) 2018-04-16 2018-04-16 Application of 2'-hydroxy-4-ethylchalcone

Country Status (1)

Country Link
PL (1) PL238124B1 (en)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BASAR N., COMPARATIVE CYTOTOXICITY OF GLYCYRRHIZA GLABRA ROOTS FRAM DIFFERENT GEOGRAPHICAL ORIGINS AGAINST IMMORTAL HUMAN KERATINOCYTE HACAT LUNG ADENOCARCINOMA A549 AND LIVER CARCINOMA HEPG2 CELIS, 2015 *
D.K. MAHAPATRA S. K. BHARTI V. ASATI, CHALCONE SCAFFOLDS AS ANTI-INFECTIVE AGENTS: STRUCTURAL AND MOLECULAR TARGET PERSPECTIVES, 2015 *
MDE L. A1VAREZ V. E. ZARELLI N. B. PAPPANO N. B. DEBATTISTA, BACTERIOSTATIC ACTION OF SYNTHETIC POLYHYDRAXYLATED CHALCONES AGAINST ESCHERICHIA COLI, 2004 *
Z. NOWAKOWSKA, A REVIEW OF ANTI-INFECTIVE AND ANTI-INFLAMMATORY CHALCONES, 2007 *

Also Published As

Publication number Publication date
PL238124B1 (en) 2021-07-05

Similar Documents

Publication Publication Date Title
NZ745678A (en) Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
BR112018014545A2 (en) probiotics for use as anti-inflammatory agents in the oral cavity
AR106644A1 (en) NUTRITIONAL SYNERGISTIC COMPOSITIONS AND USES OF THE SAME
BR102013003570A8 (en) PLATELET-RICH PLASMA COMPOSITIONS
EP3318251A3 (en) Composition for preventing or treating obesity or lipid-related metabolic disease
MD3359146T2 (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
BR112018076800A2 (en) guanidine derivative, medicament, protein 1 inhibitor of mucosal-associated lymphoid tissue lymphoma translocation, and therapeutic or prophylactic agent.
MY195760A (en) Use of IDHP in Preparation of Drug or Health Product for Prevention and Treatment of Coronary Atherosclerosis Disease
MX2007004104A (en) Use of lavender oil for the prophylaxis and treatment of neuro asthenia, somatization disorders and other diseases associated with stress.
PL425239A1 (en) Application of 2'-hydroxy-4-methylchalcone
PL425238A1 (en) Application of 2'-hydroxy-4-ethylchalcone
PL425240A1 (en) Application of 7-aminoflavone
PL425242A1 (en) Application of 3'-amino-4-carboxychalcone
PL425241A1 (en) Application of 2'-hydroxychalcone
PL425235A1 (en) Application of isoxanthohumol
WO2019040459A3 (en) Composition and nutritional supplement made therefrom
EP4234035A3 (en) A pharmaceutical combination for the treatment of a cancer
SG11201806628UA (en) New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
EA202090728A1 (en) APPLICATION OF NOR-URSODEOXYCHOLIC ACID TO REDUCE LIVER FAT
PL423329A1 (en) Application of Kamchatka berry Lonicera caerulea L. var. Kamtschatica or its tissue or the products thereof, preferably the fruit extract
ZA202104321B (en) Aqueous paediatric retinol formulations
PL421363A1 (en) Application of a cornel-tree Cornus mas L. or its tissue or the products thereof, preferably fruit extract
PL429745A1 (en) Functional protein agglomerate
PL414927A1 (en) Chewing gum that improves one's well-being (B<sub>12</sub>, D<sub>3</sub>, folic acid)